Johnson & Johnson is the vaccine that will potentially the answer to the fight against Coronavirus and it prevents hospitalizations and keeps people from dying.
Clinical trial data show that J&J’s vaccine is 66% effective overall at protecting against Covid, compared with about 95% for the Pfizer and Moderna vaccines.
Photo by hakannural on unsplash
The CEO Alex Gorsky of Johnson & Johnson had told CNBC on Monday that the company’s Covid-19 vaccine will be the answer we need to fight against the coronavirus because it prevents hospitalizations and keeps people from dying.
Johnson & Johnson is the 3rd vaccine approved for distribution in the U.S. and the only vaccine that requires just one dose and the FDA also authorizes it for emergency use. Also, Clinical trial data show that J&J’s vaccine is 66% effective overall at protecting against Covid, compared with about 95% for the Pfizer and Moderna vaccines. The company has said it plans to ship the vaccine, which contains five doses per vial, at 36 to 46 degrees Fahrenheit.
We are still scared for this new vaccine like the others, but Johnson & Johnson has it lower effectiveness rate, and the good thing is that it prevented 100% of virus-related hospitalizations and deaths, Gorsky said.
Some people have questioned whether they should get J&J’s vaccine due to the lower effectiveness rate. While the efficacy rate is lower, the most important finding of the vaccine is that it prevented 100% of virus-related hospitalizations and deaths, Gorsky said.
“There’s a lot of different ways to try and do comparisons,” Gorsky said in an interview with CNBC’s "Squawk Box” “But when you really look at what’s the objective here, keeping people out of the hospital, keeping people from dying, we believe this is an incredibly important tool to be added to health-care systems let alone for patients around the world.”
“All of these vaccines are incredibly effective,” he added.